• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX PRO TRIFOCAL TORIC UV ABSORBING IOL W/AUTONOME DELIVERY SYSTEM; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX PRO TRIFOCAL TORIC UV ABSORBING IOL W/AUTONOME DELIVERY SYSTEM; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number PXCAT3
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Visual Disturbances (2140)
Date of Event 02/10/2026
Type of Reportable Event Serious Injury
Event or Problem Description
A non-healthcare professional reported that following the cataract surgery with intraocular lens (iol) implant procedure the patient experienced excessive halos.The iol has been exchanged in a secondary procedure.Clinical reason for explant was maladaptation and negative dysphotopsia.
 
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Additional Manufacturer Narrative
Additional information provided in d.9., h.3., h.6 and h.11.The product was not returned for analysis.It was reported that, in the surgeon's opinion, the product did not cause or contribute to the event.The root cause for the reported complaint could not be determined.According to the instructions for use (ifu), some visual effects may be expected due to the superposition of focused and unfocused multiple images.These may include some perception of halos, radial lines around point sources of light (starbursts) under night-time conditions, or glare, as well as other visual symptoms.As with other multifocal iols, these visual disturbances may be significant enough in some cases that the patient may request explantation of the lens.Based on the results from the manufacturing batch record, the products met release criteria.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON PANOPTIX PRO TRIFOCAL TORIC UV ABSORBING IOL W/AUTONOME DELIVERY SYSTEM
Common Device Name
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key25043953
Report Number9612169-2026-01012
Device Sequence Number21435163
Product Code MJP
UDI-Device Identifier00380658491383
UDI-Public(01)00380658491383(17)300917(11)250919(10)26110736
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Device Explanted Year2026
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 07/21/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberPXCAT3
Device Catalogue NumberPXCAT3.230
Device Lot Number26110736
Was Device Available for Evaluation? No
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 04/07/2026
Supplement Date Received by Manufacturer06/26/2026
Initial Report FDA Received Date04/30/2026
Supplement Report FDA Received Date07/21/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/19/2025
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PROVISC OPHTHALMIC VISCOSURGICAL DEVICE
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-